Cymbiotika
PrivateLast Round
Seed
Nov 6, 2025
Total Funding Raised
$55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cymbiotika is a health and wellness company that develops and sells nutritional supplements designed to address nutritional deficiencies and support healthy aging.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Sports & Fitness, Fashion & Beauty
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cymbiotika Comparables
Compare Cymbiotika with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ritual | 89% | |
| Snap Supplements | 87% | |
| The Absorption Company | 86% |
Cymbiotika Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 6, 2025 | ||||
| Debt | Oct 16, 2024 |
Key People
Founding team and executive leadership
Cymbiotika Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RevTek Capital | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 30% month-over-month.
- Mar 13, 2026
Partnered with Ulta Beauty to launch supplements online and in stores.
Recent news
Latest coverage and updates
- partners_withAug 31, 2026
Cymbiotika partnered with Hundred on Aug 31st '26.
- launchesAug 24, 2026
Cymbiotika Llc will launch Carín Power Smoothie on Sep 3rd '26.
- recognized_asAug 14, 2026
Cymbiotika recognized as Inc. 5000 on Aug 14th '26.
- has_revenueAug 13, 2026
Cymbiotika had revenue of $150M on Jul 1st '25.
Cymbiotika Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cymbiotika's valuation, stock price, and market status.
Is Cymbiotika a public or private company?
Cymbiotika is a private company.
What is the current stock price of Cymbiotika?
Cymbiotika is a private company with no public stock price. No recent secondary market data is available.
How much is Cymbiotika worth (valuation)?
Valuation information for Cymbiotika is not publicly available.
Can I buy Cymbiotika stock?
Cymbiotika shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cymbiotika's last funding round?
Cymbiotika's most recent funding round was Seed on November 19, 2025.
Who are the main investors in Cymbiotika?
Key investors in Cymbiotika include RevTek Capital.
Will Cymbiotika IPO soon?
No public IPO plans have been announced for Cymbiotika.
How can I track Cymbiotika secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cymbiotika's secondary market activity and sign up for updates.